ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 214 filers reported holding ROYALTY PHARMA PLC in Q1 2021. The put-call ratio across all filers is 1.03 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $10,023,927 | -17.1% | 326,087 | -2.8% | 0.69% | -23.3% |
| Q1 2023 | $12,093,425 | -0.9% | 335,649 | +8.7% | 0.90% | -9.4% |
| Q4 2022 | $12,200,740 | +34.3% | 308,723 | +36.5% | 0.99% | +12.9% |
| Q3 2022 | $9,086,000 | -31.2% | 226,137 | -28.1% | 0.88% | -29.0% |
| Q2 2022 | $13,216,000 | +7.6% | 314,364 | -0.3% | 1.24% | +31.9% |
| Q1 2022 | $12,286,000 | +4.6% | 315,345 | +7.0% | 0.94% | +7.8% |
| Q4 2021 | $11,742,000 | +8.1% | 294,667 | -2.0% | 0.87% | +0.9% |
| Q3 2021 | $10,864,000 | +29.3% | 300,595 | +51.0% | 0.86% | +26.2% |
| Q2 2021 | $8,403,000 | +3.7% | 199,031 | +7.1% | 0.68% | -7.8% |
| Q1 2021 | $8,107,000 | +12.4% | 185,860 | +29.0% | 0.74% | -2.1% |
| Q4 2020 | $7,213,000 | – | 144,117 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |